Pharma news
Americas
House of Representatives introduces bill to drive down cost of prescription drugs | Places “reasonable limit” on the number of patents a manufacturer can contest to prevent patent ‘thickets’ | Companion bill passed Senate earlier this month. 23 July 2024
Europe
Paris Central Division issues its first revocation judgment in dispute brought by Meril subsidiaries in Italy, Germany and India | Decision means infringement action by Edwards can resume at Munich Local Division | Damages worth €8m ($8.7m) | Gide, Marks & Clerk, Potter Clarkson among representatives. 23 July 2024
Pharma
New bill anticipated to depart from previous government’s light-touch approach to AI regulation | Attorneys fear “onerous or conflicting” requirements on pharma and biotech companies. 16 July 2024
Americas
Proposed change will cut down ‘patent thickets’ says FTC | Biotech firms say changes will damage innovation. 11 July 2024
Europe
Double promotion includes patent attorney who challenged Novartis in G1/22 | Supplementary Protection Certificates expert also joins partnership. 2 July 2024
Pharma
Clarivate analysis identifies 140,000 patented inventions in digital health in decade to 2022 | Patentees comprise a ‘surprising mix’ of companies across various industries. 2 July 2024
Americas
US drugmaker files six lawsuits over compounded tirzepatide products | At least five deaths associated with ‘generic’ Mounjaro, according to complaint | Fears over drug's 'unapproved' use for cosmetic weight loss. 25 June 2024
Pharma
UK judge concludes neither party has ‘won’ in case between Salts and Pelican over ostomy products | Court denied Salts’ request for Model D disclosure. 25 June 2024
Americas
Can the FTC push through a law that has perturbed America’s life sciences industry? Unlikely, says the lawyer appointed by the world’s largest HR group opposing the move. 20 June 2024
Americas
South Korean firm has sued two manufacturers in Delaware alleging patent infringement | SKBP asked court to stop ANDAs from Aurobindo and Zenara until patents expire. 19 June 2024